Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
14.17
-0.38 (-2.61%)
At close: Jul 31, 2026, 4:00 PM EDT
14.19
+0.02 (0.14%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Mesoblast Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Mesoblast stock have an average target of $35, which predicts a 147.00% increase from the current stock price of 14.17.
Price Target: $35 (+147.00%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Apr 15, 2026.
Analyst Ratings
The average analyst rating for Mesoblast stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +147.00% | Apr 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $35 | Buy | Reiterates | $35 | +147.00% | Apr 10, 2026 |
Financial Forecast
Revenue This Year
117.54M
from 17.20M
Increased by 583.48%
Revenue Next Year
202.95M
from 117.54M
Increased by 72.66%
EPS This Year
-0.04
from -0.07
EPS Next Year
0.03
from -0.04
EPS and Forward PE are based on non-GAAP adjusted numbers.